Ignite Creation Date:
2025-12-25 @ 4:20 AM
Ignite Modification Date:
2026-04-24 @ 10:34 PM
Study NCT ID:
NCT00317720
Status:
COMPLETED
Last Update Posted:
2025-04-30
First Post:
2006-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2005-0471
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |